Eculizumab: A Complementary addition to existing long-term therapies for myasthenia gravis.

MLA

Edmundson, Christyn, and Amanda C. Guidon. “Eculizumab: A Complementary Addition to Existing Long-Term Therapies for Myasthenia Gravis.” Muscle & Nerve, vol. 60, no. 1, July 2019, pp. 7–9. EBSCOhost, https://doi.org/10.1002/mus.26512.

APA

Edmundson, C., & Guidon, A. C. (2019). Eculizumab: A Complementary addition to existing long-term therapies for myasthenia gravis. Muscle & Nerve, 60(1), 7–9. https://doi.org/10.1002/mus.26512

Chicago

Edmundson, Christyn, and Amanda C Guidon. 2019. “Eculizumab: A Complementary Addition to Existing Long-Term Therapies for Myasthenia Gravis.” Muscle & Nerve 60 (1): 7–9. doi:10.1002/mus.26512.